Irene Rius

[Irene Rius @IreneRiusRuiz]

@SimatsAlba @ArthurLiesz @CellCellPress Uauuu!! Congrats @SimatsAlba !!!!

[Irene Rius @IreneRiusRuiz]

@pebarba @vallhebron @Hemato_Vhebron @Sidnavigare Enhorabona Pere👏🏽👏🏽👏🏽🍾

[Vall d’Hebron Institute of Oncology (VHIO) @VHIO]

Investigadors del VHIO descobreixen com es desenvolupen diferents mecanismes de resistència en funció de les dianes emprades en els tractaments d'immunoteràpia. 

➕ https://t.co/qkrll2Qcij

[Tomás Pascual @TomasPascualMD]

Some drugs with indication approved in breast cancer by the EMA and pending or rejected in Spain.

❌Pertuzumab: adjuvant HER2+ early BC
❌Neratinib: adjuvant HER2+ early BC
❌Olaparib: gmBRCA HER2- met BC
❌Talazoparib: gmBRCA HER2- met BC
❌Tucatinib: HER2+ met BC
⬇️

[César Serrano García @DrCeSarcoma]

🙏Please RT

👩‍🔬Interested in embarking in an international PhD Program in a top-notched cancer institute @VHIO #Barcelona?

Willing to do bench-to-bedside science in #GIST #sarcoma (and also have fun) with us?
👉https://t.co/GaUDAAr9rR

Then... apply! 👇

https://t.co/ednuIhE12f

[Toni Celia-Terrassa @TCeliaTerrassa]

So delighted to share our findings in breast cancer #immunotherapy and first study of the https://t.co/fm2E1uWpRj in @Naturecancer impressively performed by the PhD student @IPerezNunez and co-directed with Dr. Joan Albanell @psmar @IMIM_research

https://t.co/hoIYXa1zJR

[Vall d’Hebron Institute of Oncology (VHIO) @VHIO]

🗞 Published in @CRC_AACR, a study led by VHIO’s @LauraSoucek, first-authored by Daniel Massó-Vallés at VHIO spin-off @peptomyc, shows that MYC inhibition by Omomyc halts disease progression in metastatic breast cancer.

➕ https://t.co/t2MoYuFKIR

[César Serrano García @DrCeSarcoma]

🙏 Por favor RT

🚨📢
ATENCIÓN: BUSCAMOS
🩺Médico especialista en Oncología Médica
🦴para una plaza de facultativo en #sarcoma
🏥en @VHIO - centro de referencia nacional y europeo
🧪y con ganas de aprender y participar en #EnsayosClínicos #Investigación

➡️https://t.co/o6qB8HIkc2

[Irene Rius @IreneRiusRuiz]

@MariaAbadMendez @elena_senis @OCT4positive @MariaAbadLab @VHIO Congrats super team!!!!!🥳🥳🥳👏🏽👏🏽

[Irene Rius @IreneRiusRuiz]

@DrCeSarcoma @oncogenejournal @VHIO @vallhebron @ibis_sevilla @EnriquedeAlava @GTRecerca @idibaps @DanaFarber @cnag_eu @DrSarcoma @SpringerNature Guau!!! Super congrats!! Specially to @DrCeSarcoma and #Alfonso! Well deserved!!👏🏽👏🏽👏🏽

[Irene Rius @IreneRiusRuiz]

@DrCeSarcoma @GrupoGeis Felicidades César!!!👏🏽👏🏽👏🏽

[Jame Abraham, MD, FACP @jamecancerdoc]

Current and Future Management of HER2-Positive #MetastaticBreastCancer @ASCO_pubs One of best reviews about this topic by @prat_aleix Timely for #ASCO21 @OncoAlert @PTarantinoMD https://t.co/wcLve2MKei

[Nature Communications @NatureComms]

Disruption of interferon-gamma signalling confers acquired cancer cell resistance to T cell-engaging therapies.
https://t.co/gpOnt9I5w0
#CancerResearch @VHIO @EnriqueJ_Arenas

[Joaquín Arribas @joaquinarribas]

Today we publish the identification of a mechanism of resistance against cancer immune therapies in @NatureComms. Congratulations to Enrique Arenas and Alex Martínez and many, many, thanks to our sponsors @SaludISCIII, @aecc_es, Ausonia and @BCRFcure

[Vall d’Hebron Institute of Oncology (VHIO) @VHIO]

🗞 Directed by VHIO’s @joaquinarribas, and first co-authored by 2 of his lab members @EnriqueJ_Arenas and Alex Martínez, a study in @NatureComms unveils a novel mechanism of resistance to T-cell bispecific antibodies and CAR-T targeting HER2 breast cancer: https://t.co/bR7vH5AsMc

[Vall d’Hebron Institute of Oncology (VHIO) @VHIO]

🔝 Vall d’Hebron supera los 100 pacientes tratados con la innovadora terapia celular CART. Actualmente, ya se han tratado pacientes con linfomas B, T y leucemias agudas linfoblásticas.

➕ https://t.co/sLrcoYirs7

#MedicinaPersonalizada

[Vall d’Hebron Institute of Oncology (VHIO) @VHIO]

🗓 El 4 de febrero es el Día Mundial contra el Cáncer. 🔬 Descubre qué hace el Grupo de Factores de Crecimiento del VHIO para conocer mejor esta enfermedad.

👉 https://t.co/tFBPA6zYP6

#EnVHIOInvestigamosPara #DiaMundialCancer #WorldCancerDay

[Irene Rius @IreneRiusRuiz]

@llmrius @VHIO @vallhebron Si! Estem molt contents! Una abraçada

[Irene Rius @IreneRiusRuiz]

Molt agraïda per haver pogut rebre la primera dosis de la vacuna contra la COVID-19! @VHIO @vallhebron #joemvacuno

[Irene Rius @IreneRiusRuiz]

@BatallaTV3 @PetitGranHotels TÀRRACO!